PharmaJet needle-free technology can improve DNA vaccine delivery 1 and has been successfully adopted into multiple cancer vaccine development programs. Partner study data shows how PharmaJet ...
CARLSBAD, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancers ...
STAFFORD, Texas--(BUSINESS WIRE)--Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to ...
More than 1,700 oncology professionals attended meeting in Orlando and online, featuring clinical and administrative updates for improving cancer care worldwide, plenary sessions on Lynch syndrome and ...
The National Comprehensive Cancer Network ® (NCCN ®) - an alliance of leading cancer centers - hosted more than 1,700 oncology professionals during the NCCN 2024 Annual Conference on April 5-7. The ...
Communications and development teams play instrumental roles at cancer centers—disseminating scientific breakthroughs and treatment advancements, sharing patient stories, raising funds, and building ...
Breast cancer experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer ...
National Comprehensive Cancer Network’s yearly conference focused on applying the latest evidence-based recommendations and fostering welcoming environments for patients and staff that lead to better ...